课题基金 / 基金详情

Outcomes Associated with Direct Rapid Genetic Testing at Time of Breast Cancer Diagnosis

Outcomes Associated with Direct Rapid Genetic Testing at Time of Breast Cancer Diagnosis
乳腺癌诊断时直接快速基因检测的相关结果
批准号:
437753
负责人:
Metcalfe Kelly A
金额:
$3.64万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2021-10-01

项目摘要

项目成果

Metcalfe Kelly A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Approximately 11% of all breast cancers are due to a mutation in a cancer predisposition gene, most frequently BRCA1 or BRCA2. These breast cancers should receive different treatments to increase the chance that a woman will survive, including bilateral m
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the Effectiveness of Breast Cancer Treatments on Health Outcomes in Women with Germline ATM Mutations
  • 批准号:
    478221
  • 项目类别:
    Operating Grants
  • 资助金额:
    $48.76万
  • 财政年份:
    2023
  • 负责人:
    Metcalfe Kelly A
  • 依托单位:
Increasing Uptake of Cascade Genetic Testing in At-Risk Family Members
  • 批准号:
    468057
  • 项目类别:
    Operating Grants
  • 资助金额:
    $49.88万
  • 财政年份:
    2022
  • 负责人:
    Metcalfe Kelly A
  • 依托单位:
Outcomes Associated with Direct Rapid Genetic Testing at Time of Breast Cancer Diagnosis
  • 批准号:
    414020
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2019
  • 负责人:
    Metcalfe Kelly A
  • 依托单位:
Genetic Testing in Females with Ovarian Cancer: Impact of Reflexive Tumour Genetic Testing on Clinical Care
  • 批准号:
    415541
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2019
  • 负责人:
    Metcalfe Kelly A
  • 依托单位:
海外基金